← Leaderboards
Joanne E Murphy-Ullrich
University Of Alabama At Birmingham
$10,767,443
Attributed
$11,945,004
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,945,004 · 14
By mechanism
R01$10,546,473 · 8
P30$926,730 · 1
R21$398,750 · 1
R13$73,051 · 4
Top collaborators
- J Crawford Downs4 shared
- Yong Zhou4 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Isabel C Scarinci$19,061,797
- Kent T Keyser$7,158,788
- Sylvie Mrug$7,272,386
- Terje Dokland$10,157,305
- Sten H Vermund$224,599,612
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsExtracellular MatrixRegulationTransforming Growth FactorsIn VitroBasePathogenesisThrombospondinsPathologicInflammationSignal TransductionMolecularMouse ModelFibrosisHuman TissueReceptorProductionAnimal ModelTissuesWound HealingPeptidesMediatingKidneyExtracellular Matrix Proteins
Grant awards (40)
Optic Nerve Head Mechanobiology in Glaucoma$434,404
R01 · FY2021 · EY
Optic Nerve Head Mechanobiology in Glaucoma$447,840
R01 · FY2020 · EY
Optic Nerve Head Mechanobiology in Glaucoma$445,761
R01 · FY2019 · EY
The thrombospondin1-TGF-beta axis in multiple myeloma$598,327
R01 · FY2018 · CA · contact PI
Optic Nerve Head Mechanobiology in Glaucoma$438,336
R01 · FY2018 · EY
2018 Biennial Conference of the American Society for Matrix Biology,Extracellular Matrix Microenvironments in Disease, Aging, and Regeneration$25,000
R13 · FY2018 · AR · contact PI
The thrombospondin1-TGF-beta axis in multiple myeloma$598,327
R01 · FY2017 · CA · contact PI
The thrombospondin1-TGF-beta axis in multiple myeloma$598,327
R01 · FY2016 · CA · contact PI
2016 American Society for Matrix Biology biennial meeting, The ECM microenvironment, a Regulatory Force in Aging and Disease$36,051
R13 · FY2016 · AG · contact PI
The thrombospondin1-TGF-beta axis in multiple myeloma$598,327
R01 · FY2015 · CA · contact PI
The thrombospondin1-TGF-beta axis in multiple myeloma$608,247
R01 · FY2014 · CA · contact PI
FASEB SRC on Matricellular Proteins in Development, Health, and Disease$4,000
R13 · FY2013 · DK · contact PI
Thrombospondin1 antagonists and diabetic nephropathy$285,508
R01 · FY2011 · DK · contact PI
Thrombospondin1 antagonists and diabetic nephropathy$288,392
R01 · FY2010 · DK · contact PI
Thrombospondins and other matricellular proteins in tissue organization and homeo$8,000
R13 · FY2010 · DK · contact PI
Thrombospondin1 antagonists and diabetic nephropathy$291,305
R01 · FY2009 · DK · contact PI
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE$198,893
P30 · FY2009 · DK · contact PI
Intermediate cell adhesion: role of calreticulin and LRP$344,902
R01 · FY2008 · HL · contact PI
Thrombospondin1 antagonists and diabetic nephropathy$291,305
R01 · FY2008 · DK · contact PI
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis$217,500
R21 · FY2008 · HL · contact PI
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE$199,030
P30 · FY2008 · DK · contact PI
Intermediate cell adhesion: role of calreticulin and LRP$344,902
R01 · FY2007 · HL · contact PI
Thrombospondin1 antagonists and diabetic nephropathy$293,560
R01 · FY2007 · DK · contact PI
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE$207,887
P30 · FY2007 · DK · contact PI
Fibroblast control of TGF-beta activation by Thy-1 and lung fibrosis$181,250
R21 · FY2007 · HL · contact PI
Intermediate cell adhesion: role of calreticulin and LRP$355,202
R01 · FY2006 · HL · contact PI
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE$160,460
P30 · FY2006 · DK · contact PI
Intermediate cell adhesion: role of calreticulin and LRP$361,666
R01 · FY2005 · HL
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis$284,130
R01 · FY2005 · DK
CORE--TISSUE CHARACTERIZATION AND IMMUNOREAGENT RESOURCE$160,460
P30 · FY2005 · DK
Regulation of TGF-beta-activity by Thrombospondin$287,000
R01 · FY2004 · HL
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis$284,130
R01 · FY2004 · DK
Regulation of TGF-beta-activity by Thrombospondin$287,000
R01 · FY2003 · HL
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis$284,130
R01 · FY2003 · DK
Regulation of TGF-beta-activity by Thrombospondin$287,000
R01 · FY2002 · HL
Diabetic Cardiomyopathy: TGFbeta activation and fibrosis$284,130
R01 · FY2002 · DK
Regulation of TGF-beta-activity by Thrombospondin$287,000
R01 · FY2001 · HL
THROMBOSPONDIN IN GLUCOSE-MEDIATED TGFB UPREGULATION$233,373
R01 · FY2001 · DK
THROMBOSPONDIN IN GLUCOSE-MEDIATED TGFB UPREGULATION$226,576
R01 · FY2000 · DK
THROMBOSPONDIN AND TENASCIN--CELL ADHESION REGULATORS$177,366
R01 · FY2000 · HL